V.M. Yakimets

V.M. Yakimets

Auto-generated profile, based on publicly available information

V.M. Yakimets

SSI “Center of Innovative Medical Technologies of the NAS of Ukraine», Kyiv

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2024 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
NKN.V. Kosei
N.V. Kosei
TTT.F. Tatarchuk
T.F. Tatarchuk
VYV.M. Yakimets
V.M. Yakimets
NIN.V. Iarotska
N.V. Iarotska
IKI.S. Kolesnichenko
I.S. Kolesnichenko
KPK.D. Plaksiieva
K.D. Plaksiieva
Objective of the study: to assess the levels of vitamin D (25(OH)D) in the blood serum of military women and women involved in a military conflict, as well as to identify the relationship of its indicators with the level of anxiety, depression and stress.Materials and methods. 52 women serving in the Armed Forces of Ukraine and other categories of women involved in the military conflict were surveyed. They entered the main group. The comparison group includes 50 women who are not related to military conflict.The concentration of vitamin D (25(OH)D) in blood serum was determined by enzyme immunoassay In all women. The level of stress was studied using the Depression Anxiety and Stress Scale (DASS-21).Results. The vast majority of women in the main group (76.5%) were diagnosed with vitamin D hypovitaminosis conditions, which significantly exceeded the specific gravity of such patients in the comparison group – 46.0% (р < 0.05). Only 12 (23.08%) women of the main group had a normal level of this vitamin, which was half as much as the specific gravity of such patients in the comparison group – 54% (р < 0.05).The values of the DASS-21 test on the depression scale were 5.74 ± 0.26 points In the main group, while in the comparison group – 4.57 ± 0.31 points (p < 0.05), on the stress scale – 8.22 ± 0.24 points and 6.67 ± 0.28 points, respectively (p < 0.05). Anxiety levels, on the contrary, were more pronounced in civilian women – 5.81 ± 0.24 points compared to the main group (р < 0.001). Signs of anxiety were found in 84.0% of civilian women and in 61.54% of women involved in the military conflict (p < 0.05). However, the specific weight of patients with different levels of this disorder almost did not differ between groups.Conclusions. Today, vitamin D deficiency is a widespread problem among women, regardless of profession. But a more pronounced decrease in its levels was found in female military personnel and other categories of women involved in the military conflict, which is related to the type of chosen profession, service conditions and psycho-emotional stress.It has been established that women who serve in the Armed Forces of Ukraine are more prone to depression and stress. Civilian women, on the other hand, show more signs of anxiety. The revealed relationship between the levels of vitamin D in the blood and elevated scores of the DASS-21 questionnaire in both groups indicates the importance of this vitamin in psycho-emotional stability. The pronounced decrease in the concentration of vitamin D, found in military women against the background of high stress load, substantiates the feasibility of a rational approach to the examination before military service and periodic determination of the vitamin D level, as well as the regular use of its adequate preventive doses.

29 September 2023 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
YAY.H. Antypkin
Y.H. Antypkin
ILI.A. Lurin
I.A. Lurin
TTT.F. Tatarchuk
T.F. Tatarchuk
NKN.V. Kosei
N.V. Kosei
VYV.M. Yakimets
V.M. Yakimets
YBY.M. Bondarenko
Y.M. Bondarenko
A review of world literature and Ukrainian researches on the most common requests to gynecologists among military women, on the structure of pathology and treatment methods was made. Special attention is paid to the hormonal contraception, namely combined oral contraceptives (COCs) in the usual and continuous regime (avoiding the hormone-free interval) and the levonorgestrel-releasing intrauterine systems (LNG-IUDs). Cases of global practice of using COCs in extended regimen were considered, which showed that 47.2% of 1156 women chose a prolonged regimen of COCs, the main reason for this was the desire to avoid symptoms associated with menstruation. We consider this option very positive for military women, because some studies show that military women who took COCs in a continuous regimen were almost twice as favorable to their reception as those who used them in a regular mode. The positive aspects of the LNG-IUDs use in military women are presented, as a factor in the prevention of abnormal uterine bleeding, reducing the risk of iron deficiency in case of possible blood loss, and reducing the intensity of dysmenorrhea as a negative factor in the military conditions. Ways to increase compliance between a gynecologist and a military woman are also considered, using the example of global studies, which prove that insufficient awareness of patients about the possible ways and positive effects of using COCs in extended regimen reduced patients’ commitment to choosing new regimens. Conclusions. In today’s realities, the gynecological service in our country faces a number of new problems that require a strategic approach and solution. World practice and national studies prove that stress-induced hormonal disorders in military women, such as abnormal uterine bleeding, menstrual cycle disorders, dysmenorrhea, are negative factors in combat conditions, require the attention and resolution by doctors. One of the options for solving this problem can be the appointment of COCs according to the usual and extended scheme or appointment of LNG-IUDs.

29 November 2024 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
TTT.F. Tatarchuk
T.F. Tatarchuk
NKN.V. Kosei
N.V. Kosei
VYV.M. Yakimets
V.M. Yakimets
KPK.D. Plaksiieva
K.D. Plaksiieva
SRSvitlana Regeda
Svitlana Regeda
APA.Y. Pylypenko
A.Y. Pylypenko
Background. Menstrual cycle disorders associated with stress, particularly functional hypothalamic amenorrhea, are a common condition among women of reproductive age in the context of martial law. Stress-induced amenorrhea not only causes reduced fertility and quality of life for women but also poses a future risk due to related general health disorders among the female population of Ukraine. There are reports in the literature about the effectiveness of etiological treatment for these disorders in the form of psychological counseling with additional supplementation, which prompted us to explore the possibilities of non-hormonal correction of stress-induced amenorrhea. Objective of the study: to optimize the treatment of stress-induced amenorrhea by non-hormonal medication therapy combined with phytotherapy alongside psychological counseling.Materials and methods. A total of 106 women of reproductive age with stress-induced amenorrhea were examined, receiving psychological counseling and medication therapy. The patients were randomized into three groups: 34 patients received Vitex agnus castus extract BNO 1095, 35 women were prescribed a preparation containing magnesium citrate and vitamin B6, and 37 participants received a combination of both treatments for six months.Results. After six months menstrual cycles were restored in 22 (64.71%) women who received Vitex agnus castus, in 19 (55.88%) patients who received magnesium citrate, and in 29 (78.4%) patients who received combined treatment. This was accompanied by the normalization of gonadotropic function of the pituitary gland, steroidogenic function of the ovaries, and endometrial thickness. Conclusions. Stabilization of the mental state and reduction of anxiety levels are key etiological interventions and essential conditions for restoring menstrual cycle regularity in patients with stress-induced amenorrhea. The mild dopaminergic support in the form of standardized Vitex agnus castus extract BNO 1095 (Cyclodynon) helps to restore hormonal balance and the menstrual cycle in women with stress-induced amenorrhea, especially when combined with magnesium supplements and psychological counseling. The obtained data allow to recommend this treatment regimen as first-line therapy for women with stress-induced amenorrhea to preserve and restore reproductive function that is especially relevant in the conditions of the military conflict in Ukraine.

2 July 2026 in Reproductive Endocrinology
Verified
Journal Article
Open access
PDF file
TTT.F. Tatarchuk
T.F. Tatarchuk
NKN.V. Kosei
N.V. Kosei
VYV.M. Yakimets
V.M. Yakimets
SRSvitlana Regeda
Svitlana Regeda
TTT.M. Tutchenko
T.M. Tutchenko
RMR.O. Mnevets
R.O. Mnevets
Objective of the study: To evaluate the effectiveness of combined therapy for cyclic mastalgia using a standardized extract of Vitex agnus castus BNO 1095 compared with magnesium therapy, alongside lifestyle modification and psychological support.Materials and methods. A total of 162 women of reproductive age with cyclic mastalgia were examined and divided into two groups. Group I (n = 79) received a standardized extract of Vitex agnus castus BNO 1095, presented as Agnus castus at a dose of 162 mg in combination with the phytocomponents Саulорhуllum thalictroides D4, Суclamen europaeum D4, Strychnos ignatia D6, Іrіs versicolor D2, Lilium tigrinum D3 as part of the complex herbal medicinal product Mastodinon® (Bionorica, Germany). Group II (n = 83) received magnesium citrate combined with vitamin B6. All participants underwent psychological counseling and lifestyle modification recommendations. The treatment duration was 6 months. Outcomes included pain intensity (NRS), sleep quality (PSQI), anxiety (GAD-7), depressive symptoms (PHQ-9), quality of life (SF-12), hormonal profile (prolactin, progesterone), and breast ultrasound characteristics.Results. In Group I, a statistically significant reduction in mastalgia intensity was observed (NRS: 7.24 ± 3.03 to 1.55 ± 1.47; p < 0.05), whereas Group II showed a less pronounced change (6.67 ± 4.33 to 4.87 ± 2.92). Anxiety levels (GAD-7) decreased significantly in Group I (7.88 ± 0.56 to 4.13 ± 0.61; p < 0.05), while no significant changes were observed in Group II. Sleep quality improved in both groups, but normalization of PSQI was more frequent in Group I. In the Vitex agnus castus group, a reduction in prolactin levels (33.55 ± 5.13 to 15.5 ± 3.12 ng/mL; p < 0.05) and an increase in progesterone levels (6.04 ± 4.01 to 16.56 ± 3.29 nmol/L; p < 0.05) were observed. More pronounced improvements in quality of life and regression of cystic breast changes according to ultrasound data were also noted.Conclusions. Complex therapy with the drug Mastodinon®, which contains a standardized extract Vitex agnus castus BNO 1095, together with lifestyle modification and psychological support is an effective approach for the treatment of cyclic mastalgia. It provides pain reduction, hormonal normalization, improvement of psycho-emotional status, sleep quality, and overall quality of life. The findings support its use as a pathogenetic first-line therapeutic option for cyclic mastalgia.